ArticleFrontiers in oncology2022

No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.

Sebastian Johannes Schober et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.